Cytosolic sulfotransferase of the SULT1 family that transfers the sulfonate group of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to small phenolic acceptors and to iodothyronines. Originally named iodothyronine sulfotransferase, it sulfates 3,3'-diiodothyronine, triiodothyronine, reverse triiodothyronine and thyroxine with higher affinity than the phenol sulfotransferases SULT1A1/SULT1A3, and it also conjugates simple phenols such as 1-naphthol and p-nitrophenol, dietary flavonoids, gut-microbial phenols, and polycyclic aromatic hydrocarbons, for which sulfation can be bioactivating rather than detoxifying. The enzyme is a soluble cytosolic protein, expressed most highly in colon and small intestinal mucosa with lower levels in liver, kidney, blood leukocytes and spleen, placing it at the first-pass barrier for orally absorbed phenolic compounds. A common coding variant (L145V, frequent in people of African ancestry) alters PAP affinity and turnover. Whether SULT1B1 additionally acts on protein substrates is disputed: a 2023 report described it as a histone sulfotransferase that sulfates tyrosine 99 of nascent histone H3, but a 2025 Matters Arising reanalysing the original mass spectra and repeating the enzyme assay found the spectra to fit a phosphotyrosine rather than a sulfotyrosine peptide and detected no sulfation of recombinant histone H3 by recombinant SULT1B1; the exchange remains unresolved.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0004062 aryl sulfotransferase activity | IBA GO_REF:0000033 | ACCEPT | Summary: Phylogenetic assertion of aryl (phenol) sulfotransferase activity across the SULT1 clade, matching the directly measured activity of human SULT1B1. Reason: Core molecular function, independently established by direct enzyme assay on the human protein, so the IBA node placement is corroborated on the target itself. Supporting Evidence: PMID:9463486 Expressed hST1B2 sulfates small phenols such as 1-naphthol and p-nitrophenol and thyroid hormones, including 3,3'-diiodothyronine, triiodothyronine, reverse triiodothyronine, and thyroxine. |
| GO:0005737 cytoplasm | IBA GO_REF:0000033 | ACCEPT | Summary: The SULT1/SULT2 families are soluble cytosolic enzymes; the phylogenetic assertion is correct for SULT1B1. Reason: Correct, although the cytosol (GO:0005829) annotations this gene also carries are more informative. |
| GO:0051923 sulfation | IBA GO_REF:0000033 | ACCEPT | Summary: The biological process matching the enzyme's catalytic activity. Reason: Correct and directly entailed by the aryl sulfotransferase activity. |
| GO:0004062 aryl sulfotransferase activity | IEA GO_REF:0000120 | ACCEPT | Summary: Automated assignment of EC 2.8.2.1 / RHEA:12164 to SULT1B1. Reason: Agrees with the experimental data; same term and action as the EXP and IDA rows. |
| GO:0005737 cytoplasm | IEA GO_REF:0000044 | ACCEPT | Summary: Transfer of the UniProt SUBCELLULAR LOCATION 'Cytoplasm' keyword, itself backed by experimental evidence from both founding papers. Reason: Correct location. |
| GO:0006790 sulfur compound metabolic process | IEA GO_REF:0000117 | MODIFY | Summary: An ARBA machine-learning assignment of a very high-level sulfur metabolism parent. Reason: Not wrong, but uninformatively general - it is a distant ancestor of the specific process this enzyme carries out. The sulfation term already annotated to this gene should be used instead. Proposed replacements: sulfation |
| GO:0008146 sulfotransferase activity | IEA GO_REF:0000120 | MODIFY | Summary: Family-level sulfotransferase assignment from the InterPro sulfotransferase domain signature. Reason: Correct but under-specific. SULT1B1's acceptor preference (phenols and iodothyronines) is established, so the aryl sulfotransferase child term should be used. Proposed replacements: aryl sulfotransferase activity |
| GO:0005515 protein binding | IPI PMID:21044950 Genome-wide YFP fluorescence complementation screen identifi... | REMOVE | Summary: Bare protein binding from a genome-wide YFP fluorescence complementation screen. Reason: "GO:0005515 carries no functional information, and this partner (UniProtKB:Q9NUX5) comes\ \ from a high-throughput two-hybrid-like screen with no follow-up implicating SULT1B1 in a complex\ \ or adapter role.". No more informative molecular function is supportable from this evidence, so the row is removed rather than rewritten. Removal does not imply the reported interaction is false. |
| GO:0005515 protein binding | IPI PMID:25416956 A proteome-scale map of the human interactome network. | REMOVE | Summary: Bare protein binding from a systematic yeast two-hybrid interactome map. Reason: Uninformative term from a high-throughput interactome screen; no specific molecular function follows from it. No more informative molecular function is supportable from this evidence, so the row is removed rather than rewritten. Removal does not imply the reported interaction is false. |
| GO:0005515 protein binding | IPI PMID:25910212 Widespread macromolecular interaction perturbations in human... | REMOVE | Summary: Bare protein binding from an interactome-perturbation survey of disease alleles. Reason: Uninformative term; high-throughput binary interaction data without functional follow-up. No more informative molecular function is supportable from this evidence, so the row is removed rather than rewritten. Removal does not imply the reported interaction is false. |
| GO:0005515 protein binding | IPI PMID:32296183 A reference map of the human binary protein interactome. | REMOVE | Summary: Bare protein binding from the HuRI binary interactome reference map. Reason: Uninformative term; high-throughput binary interaction data without functional follow-up. No more informative molecular function is supportable from this evidence, so the row is removed rather than rewritten. Removal does not imply the reported interaction is false. |
| GO:0005515 protein binding | IPI PMID:32814053 Interactome Mapping Provides a Network of Neurodegenerative ... | REMOVE | Summary: Bare protein binding from a neurodegenerative-disease interactome mapping study. Reason: Uninformative term; high-throughput interaction data with no evidence that SULT1B1 acts through protein binding. No more informative molecular function is supportable from this evidence, so the row is removed rather than rewritten. Removal does not imply the reported interaction is false. |
| GO:0042403 thyroid hormone metabolic process | IEA GO_REF:0000107 | ACCEPT | Summary: Orthology transfer from mouse Sult1b1, agreeing with the human experimental data. Reason: Consistent with the direct demonstration of iodothyronine sulfation by the human enzyme. |
| GO:0008146 sulfotransferase activity | IDA PMID:20056724 Phase II metabolism of hesperetin by individual UDP-glucuron... | MODIFY | Summary: SULT1B1 was one of twelve purified human SULTs assayed for hesperetin sulfo-conjugation. Reason: The observation is real, but the acceptor here is a phenolic flavonoid, so the aryl sulfotransferase child term is the accurate assignment. Same action as the other GO:0008146 rows. Proposed replacements: aryl sulfotransferase activity Supporting Evidence: PMID:20056724 Based on expression levels SULT1A3 and SULT1B1 also will probably play a role in the sulfo-conjugation of hesperetin in vivo. |
| GO:0004062 aryl sulfotransferase activity | EXP PMID:28084139 A high frequency missense SULT1B1 allelic variant (L145V) se... | ACCEPT | Summary: Kinetic characterization of wild-type and L145V SULT1B1 on small phenolic substrates. Reason: Direct experimental support for the core molecular function on the human protein. Supporting Evidence: PMID:28084139 Human cytosolic sulfotransferase 1B1 (SULT1B1) sulfates small phenolic compounds and bioactivates polycyclic aromatic hydrocarbons. |
| GO:0004062 aryl sulfotransferase activity | EXP PMID:9463486 Expression and characterization of a novel thyroid hormone-s... | ACCEPT | Summary: Recombinant human SULT1B1 (hST1B2) sulfates 1-naphthol and p-nitrophenol. Reason: Founding experimental evidence for the core molecular function. Supporting Evidence: PMID:9463486 Expressed hST1B2 sulfates small phenols such as 1-naphthol and p-nitrophenol and thyroid hormones, including 3,3'-diiodothyronine, triiodothyronine, reverse triiodothyronine, and thyroxine. |
| GO:0005737 cytoplasm | EXP PMID:9443824 Molecular cloning and characterization of rat ST1B1 and huma... | ACCEPT | Summary: The cloned enzyme behaves as a soluble cytosolic protein and is detected in liver cytosol. Reason: Correct; the cytosol term carried by this gene is the more precise form. |
| GO:0005737 cytoplasm | EXP PMID:9463486 Expression and characterization of a novel thyroid hormone-s... | ACCEPT | Summary: SULT1B1 was isolated and characterized as a cytosolic sulfotransferase. Reason: Correct location, supported by the founding characterization. Supporting Evidence: PMID:9463486 These results indicate that a novel cytosolic ST is present in human tissues, which may have an important role in thyroid hormone and xenobiotic metabolism. |
| GO:0042403 thyroid hormone metabolic process | IDA PMID:9463486 Expression and characterization of a novel thyroid hormone-s... | ACCEPT | Summary: Recombinant SULT1B1 sulfates T2, T3, rT3 and T4. Reason: Well-supported endogenous role; iodothyronine sulfation is the reason the enzyme was originally named iodothyronine sulfotransferase. Supporting Evidence: PMID:9463486 Expressed hST1B2 sulfates small phenols such as 1-naphthol and p-nitrophenol and thyroid hormones, including 3,3'-diiodothyronine, triiodothyronine, reverse triiodothyronine, and thyroxine. |
| GO:0004062 aryl sulfotransferase activity | IDA PMID:9443824 Molecular cloning and characterization of rat ST1B1 and huma... | ACCEPT | Summary: Recombinant human ST1B2 (SULT1B1) expressed in COS-1 cells sulfates p-nitrophenol. Reason: Direct experimental support for the core molecular function. Supporting Evidence: PMID:9443824 The recombinant forms catalyzed sulfation of p-nitrophenol, 3,3',5-triiodothyronine (T3) and dopamine, but not of beta-estradiol and dehydroepiandrosterone. |
| GO:0051923 sulfation | IDA PMID:9443824 Molecular cloning and characterization of rat ST1B1 and huma... | ACCEPT | Summary: The process term corresponding to the measured sulfotransferase reaction. Reason: Correct and directly observed. |
| GO:0006068 ethanol catabolic process | IDA PMID:23207770 Ethanol sulfation by the human cytosolic sulfotransferases: ... | MARK AS OVER ANNOTATED | Summary: SULT1B1 was one of eleven purified human SULTs screened for ethanol sulfation, and it was not among the enzymes found to be active. Reason: The cited paper's own summary names the ethanol-sulfating SULTs explicitly and SULT1B1 is not among them, so this looks like a panel-wide transfer of the screen's positive result to every enzyme tested. Additionally, sulfation of ethanol to ethyl sulfate is a minor conjugation route rather than ethanol catabolism. Flagged rather than removed because this is an experimental annotation whose full text I could not read (the cached record is abstract-only), per project policy; a curator with the full text should confirm or retire it. Supporting Evidence: PMID:23207770 A systematic analysis revealed four ethanol-sulfating SULTs, SULT1A1, SULT1A2, SULT1A3, and SULT1C4, among the eleven human SULT enzymes previously prepared and purified. |
| GO:0004062 aryl sulfotransferase activity | IDA PMID:23207770 Ethanol sulfation by the human cytosolic sulfotransferases: ... | ACCEPT | Summary: SULT1B1 was among the eleven purified, PAPS-dependent human SULT enzymes used in this systematic assay. Reason: Consistent with the established core function, even though this particular paper's positive substrate hits were other SULTs. |
| GO:0050427 3'-phosphoadenosine 5'-phosphosulfate metabolic process | IDA PMID:23207770 Ethanol sulfation by the human cytosolic sulfotransferases: ... | KEEP AS NON CORE | Summary: SULT1B1 consumes PAPS as the sulfonate donor in every reaction it catalyses. Reason: True but generic to the whole cytosolic sulfotransferase family; it describes cofactor turnover rather than a distinguishing biological role of SULT1B1. |
| GO:0051923 sulfation | IDA PMID:23207770 Ethanol sulfation by the human cytosolic sulfotransferases: ... | ACCEPT | Summary: The process term matching the assayed sulfotransferase reaction. Reason: Correct; same term and action as the other sulfation rows. |
| GO:0008146 sulfotransferase activity | IDA PMID:19548878 Inhibitory effects of kynurenic acid, a tryptophan metabolit... | MODIFY | Summary: Recombinant hSULT1B1 activity was measured in order to characterize kynurenic acid as an inhibitor. Reason: The activity is real but the general parent term is used; the aryl sulfotransferase child term is accurate for this enzyme. Same action as the other GO:0008146 rows. Proposed replacements: aryl sulfotransferase activity Supporting Evidence: PMID:19548878 KYNA also exerted an inhibitory activity towards hSULT1A1 and hSULT1B1. |
| GO:0051923 sulfation | IDA PMID:19548878 Inhibitory effects of kynurenic acid, a tryptophan metabolit... | ACCEPT | Summary: The process term matching the assayed reaction; the qualifier is weaker than the involved_in used on the other sulfation rows. Reason: Correct process. The enzyme directly performs sulfation, so involved_in would be the better qualifier, but the term assignment itself is sound. |
| GO:0030855 epithelial cell differentiation | IEP PMID:21492153 Analysis of proteomic changes induced upon cellular differen... | MARK AS OVER ANNOTATED | Summary: SULT1B1 was one of 53 spots differentially abundant between proliferating and differentiated Caco-2 cells on 2-D gels. Reason: An expression correlation during enterocyte differentiation, with no perturbation showing that SULT1B1 participates in the differentiation programme. SULT1B1 being induced in differentiated enterocytes is expected from its role in intestinal first-pass phenol conjugation and does not make it a differentiation factor. Supporting Evidence: PMID:21492153 Two-dimensional gel analysis yielded 53 proteins that were differently regulated during the differentiation process. |
| GO:0005829 cytosol | TAS Reactome:R-HSA-176474 | ACCEPT | Summary: Reactome places SULT1B1 in the cytosol as the catalyst of 3,3'-diiodothyronine sulfation. Reason: Correct and more specific than the cytoplasm annotations; consistent with the experimental localization. |
| GO:0005829 cytosol | TAS Reactome:R-HSA-176585 | ACCEPT | Summary: Reactome places SULT1B1 in the cytosol as the catalyst of T3 sulfation. Reason: Correct and specific; same term and action as the other cytosol rows. |
| GO:0006805 xenobiotic metabolic process | IDA PMID:20056724 Phase II metabolism of hesperetin by individual UDP-glucuron... | ACCEPT | Summary: Phase II sulfo-conjugation of a dietary flavanone by purified SULT1B1. Reason: Phase II conjugation of ingested phenolic compounds is a genuine physiological role for this enzyme, which is most abundant in colon and small intestinal mucosa. Supporting Evidence: PMID:28084139 SULT1B1 is expressed at highest levels throughout the human colon and small intestine but can also be found at moderate levels in human liver, kidney, and white blood cells |
| GO:0009812 flavonoid metabolic process | IDA PMID:20056724 Phase II metabolism of hesperetin by individual UDP-glucuron... | KEEP AS NON CORE | Summary: SULT1B1 conjugates hesperetin in a purified-enzyme panel. Reason: Genuine but one instance of the enzyme's broad phenolic substrate range; flavonoids are not a distinguishing physiological substrate class for SULT1B1, and the paper itself infers an in vivo role from expression level rather than from potency. Supporting Evidence: PMID:20056724 Based on expression levels SULT1A3 and SULT1B1 also will probably play a role in the sulfo-conjugation of hesperetin in vivo. |
| GO:0051923 sulfation | IDA PMID:20056724 Phase II metabolism of hesperetin by individual UDP-glucuron... | ACCEPT | Summary: The process term matching the measured conjugation reaction. Reason: Correct; same term and action as the other sulfation rows. |
| GO:0005829 cytosol | NAS PMID:9463486 Expression and characterization of a novel thyroid hormone-s... | ACCEPT | Summary: Author statement that this is a cytosolic sulfotransferase. Reason: Correct, and corroborated by the EXP cytoplasm annotations from the same and the companion paper. Supporting Evidence: PMID:9463486 These results indicate that a novel cytosolic ST is present in human tissues, which may have an important role in thyroid hormone and xenobiotic metabolism. |
| GO:0008146 sulfotransferase activity | IDA PMID:9463486 Expression and characterization of a novel thyroid hormone-s... | MODIFY | Summary: Direct demonstration of sulfotransferase activity of recombinant human SULT1B1. Reason: The activity is directly demonstrated, but the acceptors identified in this very paper are phenols and iodothyronines, so the aryl sulfotransferase child term is the accurate assignment. Same action as the other GO:0008146 rows. Proposed replacements: aryl sulfotransferase activity |
| GO:0018958 phenol-containing compound metabolic process | IDA PMID:9463486 Expression and characterization of a novel thyroid hormone-s... | ACCEPT | Summary: Sulfation of 1-naphthol and p-nitrophenol by the recombinant enzyme. Reason: This is arguably the most accurate biological-process description of what SULT1B1 does - it is the process counterpart of aryl sulfotransferase activity. Supporting Evidence: PMID:9463486 Expressed hST1B2 sulfates small phenols such as 1-naphthol and p-nitrophenol and thyroid hormones, including 3,3'-diiodothyronine, triiodothyronine, reverse triiodothyronine, and thyroxine. |
| GO:0042403 thyroid hormone metabolic process | IDA PMID:9443824 Molecular cloning and characterization of rat ST1B1 and huma... | ACCEPT | Summary: T3 sulfation by recombinant human ST1B2, with higher affinity than the phenol sulfotransferases ST1A3 and ST1A5. Reason: Core endogenous role, directly measured and kinetically compared against other human SULTs. Supporting Evidence: PMID:9443824 These data indicate that the newly characterized sulfotransferases constitute a distinct ST1 subfamily of enzymes catalyzing the sulfation of T3 as a typical endogenous substrate in rats and humans. |
| GO:0006576 biogenic amine metabolic process | TAS PMID:9443824 Molecular cloning and characterization of rat ST1B1 and huma... | KEEP AS NON CORE | Summary: Dopamine sulfation was reported for recombinant ST1B2 in this paper. Reason: Kept but demoted because the two founding papers disagree: PMID:9443824 reports dopamine sulfation while PMID:9463486 reports no activity on dopamine. UniProt follows PMID:9443824. Catecholamine sulfation in humans is dominated by SULT1A3, so even if SULT1B1 has measurable activity it is unlikely to be a physiologically distinguishing role. Supporting Evidence: PMID:9443824 The recombinant forms catalyzed sulfation of p-nitrophenol, 3,3',5-triiodothyronine (T3) and dopamine, but not of beta-estradiol and dehydroepiandrosterone. PMID:9463486 No activity was detected when several steroids or dopamine were tested as substrates. |
| GO:0008146 sulfotransferase activity | TAS PMID:9443824 Molecular cloning and characterization of rat ST1B1 and huma... | MODIFY | Summary: Author-statement sulfotransferase assignment from the cloning paper. Reason: Correct but under-specific; the same paper identifies phenolic and iodothyronine acceptors. Same action as the other GO:0008146 rows. Proposed replacements: aryl sulfotransferase activity |
Loading supporting contentβ¦
Download this section (compressed HTML)Q: Does SULT1B1 sulfate any protein substrate at all? The 2023 report that it sulfates Tyr99 of nascent histone H3 (PMID:36805701) is formally contested by a 2025 Matters Arising (PMID:40890505), which reannotated the original raw mass spectra as a phosphotyrosine rather than a sulfotyrosine peptide, obtained no sulfate-retaining fragments from a synthetic sulfopeptide standard, and saw no sulfation of recombinant histone H3.2 in an rhSULT1B1 assay that did efficiently sulfate T3. The original authors replied (PMID:40890506) and an Author Correction was issued (PMID:40890508), but nothing has been retracted. An independent laboratory repeating the in vitro sulfation assay with orthogonal, sulfate-preserving fragmentation (ETD/EThcD or negative-mode ECD rather than HCD) would settle it.
Q: If H3Y99 sulfation is real, which enzyme writes it? PMID:36805701 assigns the activity to SULT1B1, while PMID:41686426 (Cancer Res 2026) assigns the same mark to GAL3ST1 and reports that SULT1B1 levels were unchanged under the conditions that induce the mark. These two attributions are mutually inconsistent, and GAL3ST1 is a Golgi type II membrane protein whose catalytic domain faces the lumen, not the cytosol where the substrate is said to be modified.
Q: GO has a term for this claim - GO:0008476 protein-tyrosine sulfotransferase activity, with GO:0006478 peptidyl-tyrosine sulfation on the process side - and in human it is currently annotated only to TPST1 and TPST2. Should GO Consortium curators adopt a formal policy for contested molecular functions of this kind, for example annotating with a NOT qualifier once a refutation of this strength exists, rather than the current implicit policy of simply not curating either side?
Q: Is the GO:0006068 ethanol catabolic process annotation (IDA, PMID:23207770, assigned by CAFA) supportable? That paper's summary names SULT1A1, SULT1A2, SULT1A3 and SULT1C4 as the ethanol-sulfating enzymes among the eleven purified human SULTs assayed; SULT1B1 appears to have been a negative in the same panel.
Experiment: Repeat the recombinant SULT1B1 + PAPS + histone H3 reaction using a sulfate-preserving activation method for the MS readout - electron transfer dissociation (ETD/EThcD) in positive mode or electron capture/detachment dissociation in negative mode - rather than HCD or ion-trap CID, with a synthetic AYLVGLFEDTNLCAIHAK sulfopeptide and the corresponding phosphopeptide run as retention-time and fragmentation standards on the same gradient, and with blank injections between runs to exclude carryover. Include 3,3',5-triiodo-L-thyronine as the positive-control acceptor to demonstrate that the enzyme preparation is active.
Hypothesis: SULT1B1 does not catalyse sulfation of histone H3 Tyr99 or of any histone tyrosine.
Type: in vitro enzyme assay with orthogonal tandem mass spectrometry
Experiment: Dot-blot and immunoblot the antibody against a matched panel of synthetic H3 91-108 peptides - unmodified, Y99-sulfated and Y99-phosphorylated - at equal loading, and repeat the cellular immunoblot after lambda phosphatase treatment and after sulfatase or mild acid hydrolysis. A signal that collapses with phosphatase but not with sulfatase treatment would show the cellular signal is phosphorylation.
Hypothesis: The anti-H3Y99sulf antibody used in the disputed literature cross-reacts with H3Y99 phosphorylation.
Type: antibody specificity validation
Experiment: Assay purified recombinant SULT1B1 against an ethanol concentration series with [35S]PAPS alongside SULT1A1 and SULT1C4 as positive controls, quantifying ethyl sulfate formation, and report kcat/Km for each. This would confirm or retire the GO:0006068 annotation directly.
Hypothesis: SULT1B1 is not a physiological ethanol sulfotransferase.
Type: comparative steady-state kinetics
Loading supporting contentβ¦
Download this section (compressed HTML)Loading supporting contentβ¦
Download this section (compressed HTML)